Sanderson, Keia
Griffin, Russell
Anderson, Nekayla
South, Andrew M.
Swanson, Jonathan R.
Zappitelli, Michael
Steflik, Heidi J.
DeFreitas, Marissa J.
Charlton, Jennifer
Askenazi, David
Fuloria, Mamta
Hanna, Mina
Harer, Matthew W.
Slagle, Cara
Schuh, Meredith P.
Woroniecki, Robert
,
Article History
Received: 7 November 2023
Revised: 29 January 2024
Accepted: 3 February 2024
First Online: 4 March 2024
Competing interests
: For full disclosure, we provide here an additional list of other author’s commitments and funding sources that are not directly related to this study: DJA is a consultant for Baxter, Nuwellis, Seastar, and Bioporto. Over the last 24 months, his institution has received funding for education and research that is not related to this project from NIH, Baxter, Nuwellis, Medtronic, Bioporto, Portero, Lediant and Seastar. He has financial interests in patent/innovations in the area of kidney support therapies and urine collection devices. He is the Founder and Chief Scientific Officer for Zorro-Flow Inc. JRC is a consultant for Medtronics, investor in Zorro-Flow, and co-owner of Sindri Technologies, LLC. She serves on the Board of the Neonatal Kidney Collaborative (NKC).